NCT02206841Recruiting
Establishment of NAFLD Cohort and Development of Fibrosis Markers
Establishment of Non-alcoholic Fatty Liver Disease Cohort and Development of Markers to Predict Histologic Progression of Liver Fibrosis
Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 28 Jul 2014
- Start date
- 1 Jan 2014
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Seoul National University Boramae Hospital
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT02206841
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2014 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Hepatotoxic medication (e.g. amiodarone)
Other illness
- History of significant alcohol consumption
- Viral hepatitis
- Autoimmune hepatitis
- Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1-antitrypsin deficiency)
Who the study is looking for
- Patients with histologically confirmed fatty liver disease
- Patients with radiologically confirmed fatty liver disease
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul Metropolitan Government Seoul National University Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.